A report on “Pharma-Grade Synthetic Camphor Market” has been appended into the market research report database of Reports and Insights, in recent times, that promises to offer a complete analysis to its readers on the growth forecasts and development prospects of the market, together with the potential business opportunities in the industry. The study, which emphasizes the most recent business dynamics, trends, growth drivers and opportunities that are impacting the market growth, also comprises the market size and the compounded average growth rate (CAGR) for the projected period 2022 and 2030. The report on Pharma-Grade Synthetic Camphor Market also incorporates an in-depth assessment on both the macro- and micro-environmental factors that are likely to impact the market growth over the forecast period. In addition to that, analytical tools such as Porter’s five forces analysis and PESTEL analysis are utilized to reckon and gather the factors that are playing the role of the driving force for the growth of the market.
The global pharma-grade synthetic camphor market in 2022 is estimated for more than US$ 167.3 Mn and expected to reach a value of US$ 236.1 Mn by 2030 with a significant CAGR of 4.4%.
Access Sample Copy of “Pharma-Grade Synthetic Camphor Market Report”: @ https://reportsandinsights.com/sample-request/1329
Pharma-Grade Synthetic Camphor Market Dynamics
Factor like the growing demand for the private labeled topical products containing camphor is expected to boost the market growth in developed regions like North America. For instance, the demand for OTC analgesics containing pharma-grade synthetic camphor includes Walgreens Ultra Strength Muscle Rub (4% camphor), Salonpas pain relieving patch (1.2% camphor), etc. These are among private label analgesics and they do not require FDA approval and thus are gaining more popularity in the U.S. market.
Also, the rebound in global trade promoting growth for camphor exports coupled with the growing trend of self-medication amongst the patients is also responsible for fueling the demand for pharma-grade synthetic camphor in the global market, thereby propelling the market growth.
Furthermore, improving supply chain management is also providing growth opportunities for pharma-grade synthetic camphor manufacturers, as it influences high growth in emerging regions like in the Asia Pacific. For instance, Merck acquired Sigma-Aldrich in 2016. Similarly, Camphor & Allied Products Ltd., a leading Indian manufacturer of pharma grade camphor, merged their business with Oriental Aromatics Limited in 2015.
Pharma-grade synthetic camphor manufacturers also witness rising demand from topical pain management products, owing to the growth recorded in the aging population coupled with the increasing count of people suffering from chronic disease. This creates a high demand for pain management topical products, thereby boosting the market growth.
Moreover, the widespread end-users applications of products like Vicks VapoRub and the beneficial properties of pharmaceutical-grade synthetic camphor, including anti-fungal and anti-inflammatory can also be considered as the revenue-generating factors for the global pharma-grade synthetic camphor market in the projected time frame.
On the contrary, the availability of substitutes and the health risks linked with the high level of camphor are likely to hamper the demand for pharmaceutical grade synthetic camphor across the globe.
Nevertheless, the on-going research and development activities to innovate new application scope for camphor along with the mounting count of the population in emerging economies such as China, India and others is creating opportunities for growth of the global market.
View Complete TOC and Figures & Graphs of Pharma-Grade Synthetic Camphor Market Industry Report – https://reportsandinsights.com/pressrelease/pharma-grade-synthetic-camphor-market
Pharma-Grade Synthetic Camphor Market Segmentation
The global pharma-grade synthetic camphor market is segmented on the basis of formulation type, application, distribution channel, and by region.
By Formulation Type:
Topical
Inhalation
By Application:
Respiratory Disorder
Muscular Rheumatism
Counterirritant and Antipruritic
Others
By Distribution Channel:
Conventional B2B
Tenders
Direct Procurement
Wholesalers & Distributors
Online B2B
Internal Channel
External Channel
By Region:
North America
Europe
Asia Pacific
Latin America
Middle East
Africa
Pharma-Grade Synthetic Camphor Market Key Players
Key players operating in the global pharma-grade synthetic camphor market include Aldon Corporation, Fengchen Group Co., Ltd., Mangalam Organics Limited, Merck KGaA, Nippon Fine Chemical Co., Ltd., Oriental Aromatics Limited, Prinova Group LLC, Rochem International, Inc., Saptagir Camphor Limited, and Spectrum Chemical Mfg. Corp.
To view Top Players, Segmentation and other Statistics of Pharma-Grade Synthetic Camphor Industry, Get Sample Report: @ https://reportsandinsights.com/sample-request/1329
About Reports and Insights:
Reports and Insights is one of the leading market research company which offers syndicate and consulting research around the globe. At Reports and Insights we adhere to the client needs and regularly ponder to bring out more valuable and real outcomes for our customers. We are equipped with strategically enhanced group of researchers and analysts that redefines and stabilizes the business polarity in different categorical dimensions of the market.
Contact Us:
Neil Jonathan
1820 Avenue M, Brooklyn
NY 11230, United States
+1-(718) 312-8686
Find Us on Linkedin: www.linkedin.com/company/report-and-insights/